Camurus AB
STO:CAMX

Watchlist Manager
Camurus AB Logo
Camurus AB
STO:CAMX
Watchlist
Price: 573 SEK 2.14% Market Closed
Market Cap: 33.7B SEK
Have any thoughts about
Camurus AB?
Write Note

Camurus AB
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Camurus AB
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Camurus AB
STO:CAMX
Income from Continuing Operations
kr266.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Income from Continuing Operations
-kr480.4m
CAGR 3-Years
8%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Income from Continuing Operations
kr76.2m
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Income from Continuing Operations
-kr177.8m
CAGR 3-Years
-25%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Income from Continuing Operations
-kr21.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Income from Continuing Operations
-kr269.6m
CAGR 3-Years
-44%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
No Stocks Found

Camurus AB
Glance View

Market Cap
33.7B SEK
Industry
Pharmaceuticals

Camurus AB operates as a research based pharmaceutical company. The company is headquartered in Lund, Skane and currently employs 148 full-time employees. The company went IPO on 2015-12-03. The firm has a diversified research portfolio, which includes five products in clinical trials, and a number of additional product candidates in the pre-clinical phase. The Company’s product pipeline represents a mix of in-house and partnered projects in different development phases. Camurus AB is the parent company of the Group, which comprises four legal entities, namely Camurus Inc, Cubosome Inc, Camurus Development AB and Bioimplant Scandinavia AB.

CAMX Intrinsic Value
901.68 SEK
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Camurus AB's Income from Continuing Operations?
Income from Continuing Operations
266.2m SEK

Based on the financial report for Sep 30, 2024, Camurus AB's Income from Continuing Operations amounts to 266.2m SEK.

What is Camurus AB's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
-42%

Over the last year, the Income from Continuing Operations growth was -42%.

Back to Top